Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ)
CNY 13.74
(1.63%)
CNY 13.74
(1.63%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.14 Billion CNY | 145.78% |
| 2022 | 871.44 Million CNY | -15.14% |
| 2021 | 1.02 Billion CNY | 280.08% |
| 2020 | 270.17 Million CNY | 439.8% |
| 2019 | 50.05 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 100 Million CNY | 100.0% |
| 2015 | 50 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | -100.0% |
| 2012 | 47 Million CNY | -81.05% |
| 2011 | 248 Million CNY | 20.39% |
| 2010 | 206 Million CNY | 0.0% |
| 2009 | - CNY | -100.0% |
| 2008 | 30 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.86 Billion CNY | -2.66% |
| 2024 Q2 | 1.91 Billion CNY | -11.95% |
| 2024 Q1 | 2.17 Billion CNY | 1.48% |
| 2023 FY | 2.14 Billion CNY | 145.78% |
| 2023 Q2 | 1.31 Billion CNY | 23.34% |
| 2023 Q4 | 2.14 Billion CNY | 32.38% |
| 2023 Q3 | 1.61 Billion CNY | 22.64% |
| 2023 Q1 | 1.06 Billion CNY | 22.74% |
| 2022 Q3 | 765.82 Million CNY | 14.9% |
| 2022 Q1 | 919.46 Million CNY | -10.46% |
| 2022 Q4 | 871.44 Million CNY | 13.79% |
| 2022 Q2 | 666.49 Million CNY | -27.51% |
| 2022 FY | 871.44 Million CNY | -15.14% |
| 2021 Q3 | 1 Billion CNY | 0.0% |
| 2021 FY | 1.02 Billion CNY | 280.08% |
| 2021 Q1 | 570.48 Million CNY | 111.15% |
| 2021 Q2 | 1 Billion CNY | 75.44% |
| 2021 Q4 | 1.02 Billion CNY | 2.6% |
| 2020 FY | 270.17 Million CNY | 439.8% |
| 2020 Q4 | 270.17 Million CNY | 0.01% |
| 2020 Q1 | 90.06 Million CNY | 79.94% |
| 2020 Q2 | 290.17 Million CNY | 222.19% |
| 2020 Q3 | 270.15 Million CNY | -6.9% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2019 FY | 50.05 Million CNY | 0.0% |
| 2019 Q4 | 50.05 Million CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | -100.0% |
| 2017 Q1 | 100 Million CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2016 Q2 | 50 Million CNY | 0.0% |
| 2016 Q3 | 100 Million CNY | 100.0% |
| 2016 Q4 | 100 Million CNY | 0.0% |
| 2016 FY | 100 Million CNY | 100.0% |
| 2016 Q1 | 50 Million CNY | 0.0% |
| 2015 Q3 | 110 Million CNY | 83.33% |
| 2015 FY | 50 Million CNY | 0.0% |
| 2015 Q2 | 60 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | 50 Million CNY | -54.55% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | -100.0% |
| 2013 Q1 | 37 Million CNY | -21.28% |
| 2013 Q2 | - CNY | -100.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2012 Q4 | 47 Million CNY | -62.99% |
| 2012 Q1 | 202 Million CNY | -18.55% |
| 2012 Q2 | 137 Million CNY | -32.18% |
| 2012 Q3 | 127 Million CNY | -7.3% |
| 2012 FY | 47 Million CNY | -81.05% |
| 2011 FY | 248 Million CNY | 20.39% |
| 2011 Q2 | 298 Million CNY | 0.0% |
| 2011 Q3 | 284 Million CNY | -4.7% |
| 2011 Q4 | 248 Million CNY | -12.68% |
| 2010 Q4 | 206 Million CNY | 0.0% |
| 2010 FY | 206 Million CNY | 0.0% |
| 2009 FY | - CNY | -100.0% |
| 2008 FY | 30 Million CNY | 0.0% |